Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCNQ5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | NBR1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | EIF3D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | RP11-96L14.8 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | WTH3DI | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | AHDC1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | ZBTB3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | RPRM | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | NEURL1B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | SLC4A10 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |